Solís AL, Fernández-Britto RJE

Language: Spanish
References: 36
Page: 134-144
PDF size: 289.45 Kb.

ABSTRACT

Objective: to characterize bone mineral density in the lumbar spine and hips according to atherogenic risk factors.
Methods: 79 dead patients without secondary osteoporosis were studied. Postmortem densitometry of the lumbar spine and hips was performed. The levels of bone mineral density were classified according to T score in normal, osteopenia and osteoporosis. Atherogenic risk factors were taken from clinical histories which reported: people over 60 years of age, high blood pressure, smoking habit, dyslipidemia, obesity and Type 2 diabetes.
Results: the elderly, the smokers and the dyslipidemic patients presented the lowest T scores and a risk of suffering from osteoporosis of 8.7; 35.4 y 5.6 respectively. High blood pressure, obesity and diabetes did not show significant differences regarding bone mineral density, but the hypertensive ones presented a 3, 1 higher risk of suffering from osteoprosis.
Conclusions: atherogenic risk factors such as aging, smoking, dyslipidemia and high blood pressure were associated to a diminished bone mass the in lumbar spine and hips as well as a higher risk of suffering from osteoporosis.

REFERENCES

1. Tekin GO, Kekilli E, Yagmur J, Uckan A, Yagmur C, Aksoy Y, et al. Evaluation of cardiovascular risk factors and bone mineral density in post menopausal women undergoing coronary angiography. Int J Cardiol. 2008;131(1):66-9.

2. Anagnostis P, Karagiannis A, Kakafika AI, Tziomalos K, Atrios VG, Mikhailidis DP. Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? Osteoporos Int. 2009;20:197-207.

3. Shaffer JR, Kammerer CM, Rainwater DL. Decreased bone mineral density is correlated with increased subclinical atherosclerosis in older, but not younger, Mexican American women and men: the San Antonio Family Osteoporosis Study. Calcif Tissue Int. 2007;81:430-41.

4. Mendoza S, Noa M, Más R. Osteoporosis y enfermedad cardiovascular. Rev CENIC Ciencias Biológicas. 2007;38(2):114-23.

5. Abad Manteca L, Izquierdo E, Andres M, Vega G, Mendo M, Pérez Castrillon JL. Prevalencia de osteoporosis en pacientes con síndrome coronario agudo. Rev Osteoporos Metab Miner. 2010;2(1):15-22.

6. Rahman MM, Laher I. Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol. 2007;5:276-92.

7. Delgado Casado N, Tirado Miranda R, Aranda Valle C, Guisado Espartero E, Mejías Real I, Navarro Hidalgo D. Patrón tomográfico de permeabilidad ósea sugestivo de osteoporosis secundaria. Rev Osteoporos Metab Miner. 2010;1:55-8.

8. Blake GM, Fogelman I. An update on dual-energy x-ray absorptiometry. Semin Nucl Med. 2010;40(1):62-73.

9. Gómez Alonso C, Díaz López JB. Métodos de determinación de la densidad mineral ósea. Rev Clin Esp. 2009;209(1):15-22.

10. Sweet MG, Sweet JM, Jeremiah MP, Galazka SS. Diagnosis and treatment of osteoporosis. Am Fam Phys. 2009;79(3):193-200.

11. Paradiñeiro Somoza A, Valero Crespo LM. Patología de la mineralización ósea (y II): osteoporosis. Medicina General. 2009;123:747-57.

12. Sosa Henríquez M, Gómez Díaz J. La osteoporosis. Definición, importancia. fisiopatología y clínica. Rev Osteoporos Metab Miner. 2010;2(5):3-7.

13. Del Pino Montes J. Epidemiología de las fracturas osteoporóticas: las fracturas vertebrales y no vertebrales. Rev Osteoporos Metab Miner. 2010;2(5):8-12.

14. Sosa Henríquez M, Díaz Curiel M. Prevalencia de fracturas vertebrales en pacientes que acuden a la consulta externa de Medicina Interna. Rev Osteoporos Metab Miner. 2010;1:9-13.

15. Valtola A, Honkanen R, Kroger H, Tuppurainen M, Saarikoski S, Alhava E. Lifestyle and other factors predict ankle fractures in perimenopausal women: a populationbased prospective cohort study. Bone. 2002;30(1):238-42.

16. Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int. 2001;68:259-70.

17. Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL. Smoking and bone metabolism in elderly women. Bone. 2000;27:429-36.

18. Broulik PD, Kapitola J. Interelations between body weight, cigarette smoking and spine mineral density in osteoporotic Czech women. Endocr Regul. 1993;27:57-60.

19. Tanko LB, Bagger YZ, Nielsen SB, Christiansen C. Does serum colesterol contribute to vertebral bone loss in postmenopausal women? Bone. 2003;32:8-14.

20. Pérez-Castrillón JL, De Luis D, Martín-Escudero JC, Asensio T, Del Amo R, Izaola I. Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors. J Diabetes Complications. 2004;18(6):317-21.

21. Gupta G, Aronow WS. Atherosclerotic vascular disease may be associated with osteoporosis or osteopenia in postmenopausal women: A preliminary study. Arch Gerontol Geriatr. 2006;43(2):285-8.

22. Solomon DH, Avorn J, Canning CF, Wang PS. Lipids levels and bone mineral density. Am J Med. 2005;118:1414.e1-1414.e5.

23. Bagger YZ, Rasmussen HB, Alexandersen P, Werge T, Christiansen C, Tankó LB. PERF study group. Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se? Osteoporos Int. 2007;18(4):505-12.

24. Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, et al. Plasma lipids and osteoporosis in postmenopausal women. Endocr J. 2002;49(2):211-7.

25. Poli A, Bruschi F, Cesana B, Rossi M, Paoletti R, Crosignani PG. Plasma low density lipoprotein cholesterol and bone mass in postmenopausal women. Obstet Gynecol. 2003;102:922-6.

26. Samelson EJ, Cupples LA, Hannan MT, Wilson PWF, Williams SA, Vaccarino V, et al. Long-term effects of serum cholesterol on bone mineral density in women and men: The Framingham Osteoporosis Study. Bone. 2004;34:557-61.

27. Makovey J, Sheng JS, Hayward C, Williams FM, Sambrook PN. Association between serum cholesterol and bone mineral density. Bone. 2009;44:208-13.

28. Hernández JL, Olmos JM, Ramos C, Martínez M, De Juan J, Valero C. Serum lipids and bone metabolism in spanish men: the Camargo Cohort Study. End J. 2010;57:51-60.

29. Perez-Castrillon JL, Justo I, Sanz-Cantalapiedra A, Pueyo C, Hernandez G, Dueñas A. Effect of the Antihypertensive Treatment on the Bone Mineral Density and Osteoporotic Fracture. Current Hypert Rev. 2005;1:61-6.

30. Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bonemineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet. 1999;354(9183):971-5.

31. Orwoll ES, Bevan L, Phipps KR. Determinants of bone mineral density in older men. Osteoporos Int. 2000;11:815-21.

32. Pérez-Castrillón JL, Martín-Escudero JC, Alvarez-Manzanares P, Cortes Sancho R, Iglesias Zamora S, García Alonso M. Hypertension as a risk factor for hip fracture. Am J Hypertens. 2005;18:146-7.

33. Perez-Castrillon JL, Sanz A, Silva J, Justo I, Velasco E, Dueñas A. Calcium-sensing receptor gene A986S polymorphism and bone mass in hypertensive women. Arch Med Res. 2006;37(5):607-11.

34. Santana Rondón G, Solís Alfonso L, Gonzáles López A. Evaluación de osteoporosis y aterosclerosis carotídea en relación a enfermedad cerebrovascular oclusiva. Rev Chilena de Radiología. 2010;16(3):136-46.

35. Hsu YH, Venners SA, Terwedow HA, Feng Y, Niu T, Li Z, et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr. 2006;83(1):146-54.

36. Pérez López G, Penacho M, Cano Megías M, González Albarrán M, Becerra Fernández A. Factores clínicos y bioquímicos relacionados con la densidad mineral ósea y el metabolismo mineral en mujeres con diabetes mellitus 2. Rev Osteoporos Metab Miner. 2010;2;3:22-32.